Hot Pursuit     01-Sep-22
Alembic Pharmaceuticals Ltd down for fifth straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 643.55, down 0.72% on the day as on 13:19 IST on the NSE. The stock in last one year as compared to a 1.9% in NIFTY and a 13% up 67.17% in the Nifty Metal index.

Alembic Pharmaceuticals Ltd is down for a fifth straight session today. The stock is quoting at Rs 643.55, down 0.72% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 1.12% on the day, quoting at 17561.25. The Sensex is at 58864.33, down 1.13%.Alembic Pharmaceuticals Ltd has lost around 8.06% in last one month.Meanwhile, Nifty Metal index of which Alembic Pharmaceuticals Ltd is a constituent, has eased around 1.57% in last one month and is currently quoting at 12699.4, down 0.95% on the day. The volume in the stock stood at 93684 shares today, compared to the daily average of 1.1 lakh shares in last one month.

The PE of the stock is 18.91 based on TTM earnings ending June 22.

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 2.41% in the September 2023 quarter
 ( Results - Announcements 07-Nov-23   15:08 )
  Alembic Pharmaceuticals to discuss results
 ( Corporate News - 17-Oct-23   10:13 )
  Alembic Pharma get US FDA nod for acne topical gel
 ( Hot Pursuit - 08-Aug-22   11:19 )
  Alembic Pharmaceuticals receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel
 ( Corporate News - 08-Aug-22   11:04 )
  Volumes jump at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 21-Feb-23   11:00 )
  Alembic Pharmaceuticals AGM scheduled
 ( Corporate News - 06-Jun-23   18:21 )
  Alembic Pharmaceuticals consolidated net profit declines 85.86% in the March 2022 quarter
 ( Results - Announcements 02-May-22   16:33 )
  Alembic Pharmaceuticals to hold board meeting
 ( Corporate News - 28-Jan-22   17:38 )
  Alembic Pharmaceuticals Ltd eases for fifth straight session
 ( Hot Pursuit - 22-Feb-22   13:35 )
  Alembic Pharmaceuticals to declare Quarterly Result
 ( Corporate News - 20-Apr-21   16:38 )
  Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 30-May-24   14:49 )
Other Stories
  Eicher Motors CV sales rises 11% YoY in June’24
  01-Jul-24   15:39
  Atul Auto hits record high as sales double to 2,628 units in Jun’24
  01-Jul-24   15:29
  Ashok Leyland slides as total sales slips 2% YoY in June'24
  01-Jul-24   15:16
  Reliance Infrastructure Ltd leads losers in 'A' group
  01-Jul-24   15:00
  Oriental Carbon & Chemicals Ltd leads losers in 'B' group
  01-Jul-24   14:45
  Rane Holdings hits life high on plan to acquire 51% stake in JV
  01-Jul-24   14:45
  Maruti Suzuki rises as total sales jumps 12% YoY in Jun’24
  01-Jul-24   14:37
  Volumes jump at Emami Ltd counter
  01-Jul-24   14:30
  Karur Vysya Bank advances climb 16% YoY in Jun'24
  01-Jul-24   14:14
  SML Isuzu jumps as June sales surges 38% YoY
  01-Jul-24   14:13
Back Top